Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03160079
Title Blinatumomab and Pembrolizumab for Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia With High Marrow Lymphoblasts
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Matthew Wieduwilt, M.D., Ph.D.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UCSF Fresno Community Cancer Institute Clovis California 93611 United States Details
UC San Diego Moores Cancer Center La Jolla California 92093 United States Details
UC Irvine Health Chao Family Comprehensive Cancer Center Orange California 92868 United States Details
UCSF Comprehensive Cancer Center San Francisco California 94143 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field